Piperine depresses the migration progression via downregulating the Akt/mTOR/MMP‑9 signaling pathway in DU145 cells.

Molecular Medicine Reports
Yuan Zeng, Ying Yang

Abstract

Piperine, an alkaloid derived from natural products, has been demonstrated to exert antitumor activities in vivo and in vitro. However, its anti‑tumor effect has not yet been illustrated in the prostate cancer (PCa) metastatic process. Thus, the present study explored the influence of piperine on PCa and the underlying molecular mechanism. Cell migration was detected via the Transwell chamber model. Total protein was identified by western blot analysis. The data revealed that piperine markedly repressed cell proliferation and migration, and induced apoptosis in PCa DU145. In addition, LY294002, an protein kinase B (Akt) inhibitor, greatly suppressed the expression level of phospho (p)‑Akt, matrix metalloproteinase (MMP)‑9 and p‑mammalian target of rapamycin (mTOR), suggesting that the activation of the Akt/mTOR/MMP‑9 signaling pathway may participate in regulating cell migration in PCa. Furthermore, piperine reduced the expression of p‑Akt, MMP‑9 and p‑mTOR. Together, these data indicated that piperine may serve as a promising novel therapeutic agent to better overcome PCa metastasis.

References

Oct 14, 2000·Methods and Findings in Experimental and Clinical Pharmacology·R Mittal, R L Gupta
Jul 15, 2005·JAMA : the Journal of the American Medical Association·Nima SharifiWilliam L Dahut
Jun 4, 2011·International Journal of Oncology·Aditya V ShettyMunirathinam Gnanasekar
Aug 21, 2012·The Journal of Nutritional Biochemistry·Carolyn D DoucetteDavid W Hoskin
Aug 14, 2013·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Dong-yun OuyangXian-hui He
Jun 2, 2014·Tuberculosis·Sandeep SharmaInshad Ali Khan
Dec 3, 2014·Cancer Letters·Anna L GreenshieldsDavid W Hoskin
Apr 23, 2016·Frontiers in Bioscience (Landmark Edition)·Huixing ChenXiaofei Wen
Aug 4, 2016·Apoptosis : an International Journal on Programmed Cell Death·Ozge BerrakNarçin Palavan-Unsal
Dec 3, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Dongli ZhangYanyun Li
Jan 12, 2017·Molecular and Cellular Biochemistry·Xiao-Lin AiZhi-Yong Wang
May 17, 2017·World Journal of Urology·Matthew R Cooperberg, June M Chan
Nov 5, 2017·Cold Spring Harbor Perspectives in Medicine·Alexander DiasRos Eeles

❮ Previous
Next ❯

Citations

Jan 18, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Di ChenWenjuan Yang
May 1, 2021·International Journal of Molecular Sciences·Karolina WojtowiczRadosław Januchowski

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry

Software Mentioned

SPSS
Quantity One

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.